An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks

Save

Report Abuse

Description

The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer.

Primary Objective

To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk.

Secondary Objective

To build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.

Study Overview

Start Date
December 13, 2022
Completion Date
June 1, 2026
Enrollment
1300
Date Posted
November 15, 2022
Accepts Healthy Volunteers?
No
Gender
All

Locations

Full Address
St. Jude Children's Research Hospital
Memphis, Tennessee 38105, United States

Eligibility

Study Population
All participants who meet eligibility criteria and consent to enrollment on the study.
Minimum Age (years)
22
Eligibility Criteria
Inclusion Criteria:

SJLIFE participant and 22 years of age or older at time of enrollment
Participant or legal guardian is able and willing to give informed consent
At least 5 years after childhood cancer diagnosis

Exclusion Criteria:

Been diagnosed with cardiomyopathy on previous SJLIFE ECG
Currently on heart medication

Study Contact Info

Study Contact Name
Melissa Hudson, MD
Study Contact Email
Study Contact Phone

Contact Listings Owner Form

An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
No
FDA Regulated Device?
No
Detailed Description
The proposed study is looking to compare the 30 second ECG read from a smartwatch to the clinical ECG during a SJLIFE scheduled ECG appointment.
NCTid (if applicable)
NCT05617391